A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

NCT07745504 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Cagrilintide
DRUG: Placebo cagrilintide
DRUG: Placebo semaglutide

Sponsor

Novo Nordisk A/S